Spain · AEMPS CIMA

CAMLAD 16 MG/5 MG/12,5 MG CÁPSULAS DURAS

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
89107
Form
CÁPSULA DURA
Composition / generic term
candesartán + amlodipino + hidroclorotiazida
Source strength
16 mg/5 mg/12,5 mg
Authorisation holder
Adamed Laboratorios S.L.U.
Marketed in source snapshot
Yes

Source-listed ingredients

  • CANDESARTAN CILEXETILO — 16 mg
  • AMLODIPINO BESILATO — 6,94 mg
  • HIDROCLOROTIAZIDA — 12,5 mg

These values do not establish equivalence or a dose recommendation.

Packages

  • CAMLAD 16 MG/5 MG/12,5 MG CÁPSULAS DURAS, 30 cápsulas

Source and coverage

Open AEMPS CIMA

Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Spain records →